Despite disappointing results in trials utilizing anti-CXCR4 strategies [23, 24], the CXCR4/SDF-1 axis warrants further study to define its role in tumor progression, recurrence, and metastasis, as well as elucidate the impact on the tumor microenvironment. The gene discussed is CXCR4; the disease is neoplasm.